Sponsor
ANRS, Emerging Infectious Diseases
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name ANRS, Emerging Infectious Diseases appears in 156 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownFrailty, Geriatric Syndromes and Care Pathways of Older Adults Living With HIV in West AfricaNCT07355413 · lead sponsor · 2026-09-28
RECRUITINGEfficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.NCT05813964 · lead sponsor · 2024-06-05
RECRUITINGPhase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART ControlNCT05300035 · lead sponsor · 2024-04-11
RECRUITINGTnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitisNCT05590455 · lead sponsor · 2023-04-11
RECRUITINGIntensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous MeningitisNCT04145258 · lead sponsor · 2021-02-07
RECRUITINGthe ANRS CO21 " Extreme " Cohort (CODEX)NCT01520844 · lead sponsor · 2012-02-01
RECRUITINGImmunotherapy With Glatiramer Acetate in PLWHIV in Poor Immunological Responders on Antiretroviral TherapyNCT07851337 · lead sponsor · 2026-12-01
NOT_YET_RECRUITINGDetection of Specific Metabolic Signatures by Nuclear Magnetic Resonance or Metabolomic NMR in Correlation With Markers of Inflammation or Immune Activation and the Risk of Developing Neurocognitive Disorders - Longitudinal Retrospective Study Nested in the ANRS12225 PEDIACAM III CohortNCT07770568 · lead sponsor · 2026-08-01
NOT_YET_RECRUITINGIntestinal Tissue-Resident Memory T Cells and HIV-1 Persistence During Antiretroviral TherapyNCT07656077 · lead sponsor · 2026-08-01
NOT_YET_RECRUITING"Pregnancy and Viral Infections: Impact on Pregnant Women and Their Children. French Prospective Cohort"NCT07412977 · lead sponsor · 2026-02-01
NOT_YET_RECRUITINGStudy of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 DiagnosisNCT07146529 · lead sponsor · 2025-09-01
NOT_YET_RECRUITINGHIV-1 Non-group M in Cameroon : Study of Genotypic and Phylogenetic Diversity (OBSOCAM)NCT06913959 · lead sponsor · 2025-06-30
NOT_YET_RECRUITINGPrevalence of Drug-resistant Hiv-1 Strains in Patients Experiencing Virologic Failure. (MULTIVIR2025)NCT06842706 · lead sponsor · 2025-04-01
NOT_YET_RECRUITINGStudy Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2 Antiviral Treatment Relief Strategies, in Patients Co-infected with the HIV-1 and HBV VirusesNCT06338826 · lead sponsor · 2025-02-01
NOT_YET_RECRUITINGImmunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow Fever VaccinationNCT05450770 · lead sponsor · 2024-11-01
UNKNOWNHPV Infection, Sexually Transmitted Infections and Anal Dysplasia in the Transgender PopulationNCT05981807 · lead sponsor · 2024-10-15
COMPLETEDPilot Implementation of HIV Self-testing Delivery in Private Pharmacies Combined to a Respondent Driven Sampling Method to Improve HIV Testing for MSM and TGW in Phnom Penh - ANRS 0100sNCT05745168 · lead sponsor · 2024-06-01
NOT_YET_RECRUITINGAssisted Notification of Partners of Men Having Sex With Men Discovering Their SeropositivityNCT06419491 · lead sponsor · 2024-06-01
UNKNOWNNegative Serology by Immunoenzymatic Test (EIA) in HIV-infected Children Treated Early With Antiretroviral in the ANRS-Pediacam Study: Pathophysiological MechanismsNCT06302933 · lead sponsor · 2024-05-02
UNKNOWNImpact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France.NCT06273943 · lead sponsor · 2024-04-01
NOT_YET_RECRUITINGImplementation and Effectiveness of Physical Activity to Prevent Disability in HIV-infected Adults Older Than 50 From Côte d'IvoireNCT06139497 · lead sponsor · 2023-10-31
ACTIVE_NOT_RECRUITINGSeroprevalence of Monkeypox Infection Among People Living With HIV and PrEP UsersNCT05922735 · lead sponsor · 2023-09-01
UNKNOWNAssessment of HIV Remission Upon cART Interruption in Early Treated Individuals Carrying the MHC B35/53Bw4TTC2 GenotypeNCT05482854 · lead sponsor · 2023-03-20
UNKNOWNEvaluation of the Safety and the Tolerability of a Combination of Two HIV Inducers in Patients With Undetectable Viral LoadNCT05230368 · lead sponsor · 2022-12-14
COMPLETEDAging With HIV and Neurocognitive Decline, a Follow-up StudyNCT05385588 · lead sponsor · 2022-11-14
COMPLETEDA Prophylactic HIV Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DREP Alone and in Combination With a Clade C ENV Protein in Healthy HIV-uninfected AdultsNCT04844775 · lead sponsor · 2022-08-05
COMPLETEDExpectation, Motivation and Experience of HIV-patients Regarding Participation to an HIV Cure-related Clinical TrialNCT05280392 · lead sponsor · 2022-06-21
TERMINATEDA HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)NCT04120415 · lead sponsor · 2022-06-21
COMPLETEDLarge Scale Transition to a Dolutegravir-based First-line ART in the South: Virological Response and Impact on HIV Drug Resistance in a Real Life Context (DoReaL Study)NCT05312918 · lead sponsor · 2022-05-01
UNKNOWNDetermination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune SuppressionNCT04738812 · lead sponsor · 2022-04-21
COMPLETEDDrug Use & Infections in ViEtnam: Mental Health Intervention for INjecting Drug UsersNCT05886504 · lead sponsor · 2022-03-28
COMPLETEDEvaluation of Measurement of Maternal Viral Load at Delivery to Optimise Post-natal Prophylaxis of HIV-exposed NewbornsNCT05017558 · lead sponsor · 2022-03-01
UNKNOWNHealth and Migration Trajectories of Housekeepers in BamakoNCT05472051 · lead sponsor · 2022-02-28
COMPLETEDPartner Notification of Sexually Transmitted Infections (STIs) in Testing CentersNCT04921618 · lead sponsor · 2021-07-12
UNKNOWNPrevalence and Longitudinal Follow-up of Anal Lesions, HPV Infection and Associated Sexually Transmitted Infections Among Men Who Have Sex With Men in Togo.NCT04910438 · lead sponsor · 2021-06-24
UNKNOWNDual Therapy in HIV Patients in 4 Days a Week Versus 7 Days a WeekNCT04867083 · lead sponsor · 2021-06-21
UNKNOWNANRS 12406 EvvA StudyNCT04593979 · lead sponsor · 2021-04-15
UNKNOWNHIV Acquisition and Life Course of Born-abroad Men Who Have Sex With Men Living in Ile-de-France: the GANYMEDE StudyNCT04684758 · lead sponsor · 2021-04-14
COMPLETEDDose Escalation Trial of CD40.HIVRI.Env Vaccine Combined or Not With a DNA-HIV-PT123 HIV-1 Vaccine in Healthy VolunteersNCT04842682 · lead sponsor · 2021-03-29
COMPLETEDCombined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP)NCT04597424 · lead sponsor · 2021-01-19
COMPLETEDANRS 12392 Sanu GundoNCT04482010 · lead sponsor · 2020-11-29
UNKNOWNNational Survey About Trajectory and Life Conditions of HIV Trans People in FranceNCT04849767 · lead sponsor · 2020-10-01
COMPLETEDPreventing Childhood HIV: Rescue Intervention. ANRS 12388 PREVENIR-PEVNCT03869944 · lead sponsor · 2019-12-04
UNKNOWNReducing Antiretroviral TreatmentsNCT04051970 · lead sponsor · 2019-11-27
TERMINATEDSexual and Reproductive Health (Including PrEP and HBV) for Female Sex Workers in Côte d'IvoireNCT03985085 · lead sponsor · 2019-11-26
UNKNOWNHUSH Restriction in HIV Infected PatientsNCT04172480 · lead sponsor · 2019-10-01
UNKNOWNHIV and HCV Infections in 2 Communes From the Battambang Province, Cambodia: Prevalence Rates, Viral Strains, and Unsafe Injection Practices (12352 ANRS ROK INVEST)NCT04044586 · lead sponsor · 2019-09-01
UNKNOWNANRS12373 GUNDO SO - Evaluation of an Empowerment Program for WLHIV in MaliNCT03795415 · lead sponsor · 2019-05-27
UNKNOWNFrailty in People Living With HIV Aged 70 Years or MoreNCT03958786 · lead sponsor · 2019-05-15
UNKNOWNEvaluation of Triage Options After HPV Testing for Cervical Cancer Screening Among HIV-infected WomenNCT03789513 · lead sponsor · 2019-03-01
UNKNOWNAn HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic InfectionNCT02972450 · lead sponsor · 2019-02-20
TERMINATEDEvaluation of Third-line cART Regimen in Cambodia (3DICAM)NCT03602690 · lead sponsor · 2018-10-04
UNKNOWNRole of the IL33/Amphiregulin Pathway as a Potential Therapeutic Target in HIV InfectionNCT03622177 · lead sponsor · 2018-09-01
UNKNOWNA Chronological Study of the Formation of HIV Cellular Reservoirs Through the Expression of Surface Markers on CD4 + T Lymphocytes, Including CD32aNCT03298360 · lead sponsor · 2018-06-28
COMPLETEDMicro RNA as Prediction and/or Prognostic Markers of IRIS in TB-HIV Co-infected PatientsNCT03941210 · lead sponsor · 2018-03-01
UNKNOWNANRS CO24 OncoVIHAC (Onco VIH Anti Checkpoint)NCT03354936 · lead sponsor · 2018-01-17
UNKNOWNAccess to PrEP for MSM: Acceptability and Feasibility in Community-based Clinics in West Africa (CohMSM-PrEP)NCT03459157 · lead sponsor · 2017-11-20
COMPLETEDAntiretroviral Treatment Taken 4 Days Per Week Versus Continuous Therapy 7/7 Days Per Week in HIV-1 Infected PatientsNCT03256422 · lead sponsor · 2017-09-07
COMPLETEDPrevention of HIV in "Île-de-France"NCT03113123 · lead sponsor · 2017-05-03
UNKNOWNNational Multicenter Trial Evaluating Two Treatments in Patients With Primary Human Immunodeficiency Virus (HIV-1) InfectionNCT02987530 · lead sponsor · 2017-04-11
COMPLETEDSponsor roles
lead sponsor140
collaborator16
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.